A Study of MHB118C Injection in Patients With Advanced Solid Tumors

Clinical trial NCT07045454 · RECRUITING

Trial details

NCT number: NCT07045454
Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignant Solid Tumor

Start date: 2025-03-31
Primary completion: 2029-03-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.